Correlation between soluble serum CD16 (sCD16) levels and disease stage in patients with multiple myeloma
β Scribed by C. Mathiot; J. -L. Teillaud; M. Elmalek; V. Mosseri; L. Euller-Ziegler; A. Daragon; B. Grosbois; J. -L. Michaux; T. Facon; J. -F. Bernard; B. Duclos; M. Monconduit; W. H. Fridman
- Publisher
- Springer
- Year
- 1993
- Tongue
- English
- Weight
- 986 KB
- Volume
- 13
- Category
- Article
- ISSN
- 0271-9142
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract Hepatocyte growth factor (HGF) has been shown to be involved in angiogenesis, epithelial cell proliferation, and osteoclast activation. HGF and its receptor are expressed on myeloma cell lines and could be involved in the pathogenesis of bone destruction in multiple myeloma (MM). The ai
## Abstract Urinary crossβlinked Nβtelopeptide of type I collagen (NTx) has been reported to be a sensitive and specific marker of bone resorption in multiple myeloma (MM). In this study, we measured the levels of NTx in 30 newly diagnosed MM patients and 25 controls. We examined its association wi
## Abstract Clonal plasma cells (PC) from different types of monoclonal gammopathies (MG) display distinct phenotypes consistent with an increased antigenβpresentation and Tβcell costimulation in MG of undetermined significance that deteriorates in malignant conditions. Expression of other cell sur
## Abstract ## BACKGROUND A prospective study was undertaken within the Gynecologic Oncology Group to determine whether serum levels of soluble tumor necrosis factor receptors I (sTNFRβI) and II (sTNFRβII), alone or in combination with CA 125, were associated with clinicopathologic characteristics